{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:27:44Z","timestamp":1783794464971,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03479-4","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T18:02:22Z","timestamp":1691776942000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of resveratrol on polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2328-6801","authenticated-orcid":false,"given":"Muhammad Omar","family":"Larik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ashhal","family":"Iftekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"3479_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"R. Azziz, E. Carmina, D. Dewailly et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91, 456\u2013488 (2009). https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035","journal-title":"Fertil Steril"},{"key":"3479_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25, 544\u2013551 (2010). https:\/\/doi.org\/10.1093\/humrep\/dep399","journal-title":"Hum Reprod"},{"key":"3479_CR3","doi-asserted-by":"publisher","first-page":"299.e1","DOI":"10.1016\/j.ajog.2012.07.023","volume":"207","author":"EM Okoroh","year":"2012","unstructured":"E.M. Okoroh, W.C. Hooper, H.K. Atrash, H.R. Yusuf, S.L. Boulet, Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008. Am J Obstet Gynecol 207, 299.e1\u20137 (2012). https:\/\/doi.org\/10.1016\/j.ajog.2012.07.023","journal-title":"Am J Obstet Gynecol"},{"key":"3479_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"D. Lizneva, L. Suturina, W. Walker, S. Brakta, L. Gavrilova-Jordan, R. Azziz, Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106, 6\u201315 (2016). https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"key":"3479_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41\u201347 (2004). https:\/\/doi.org\/10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"3479_CR6","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/ptr.6487","volume":"33","author":"S Abdollahi","year":"2019","unstructured":"S. Abdollahi, A. Salehi-Abargouei, O. Toupchian et al. The effect of resveratrol supplementation on cardio-metabolic risk factors in patients with type 2 diabetes: a randomized, double-blind controlled trial. Phytother Res 33, 3153\u20133162 (2019). https:\/\/doi.org\/10.1002\/ptr.6487","journal-title":"Phytother Res"},{"key":"3479_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","volume":"1","author":"AY Berman","year":"2017","unstructured":"A.Y. Berman, R.A. Motechin, M.Y. Wiesenfeld, M.K. Holz, The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis. Oncol. 1, 35 (2017). https:\/\/doi.org\/10.1038\/s41698-017-0038-6","journal-title":"Oncol."},{"key":"3479_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/nu8030145","volume":"8","author":"C Buhrmann","year":"2016","unstructured":"C. Buhrmann, P. Shayan, B. Popper, A. Goel, M. Shakibaei, Sirt1 is required for resveratrol-mediated chemopreventive effects in colorectal cancer cells. Nutrients. 8, 145 (2016). https:\/\/doi.org\/10.3390\/nu8030145","journal-title":"Nutrients."},{"key":"3479_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.foodchem.2015.12.083","volume":"199","author":"K Farhadi","year":"2016","unstructured":"K. Farhadi, F. Esmaeilzadeh, M. Hatami, M. Forough, R. Molaie, Determination of phenolic compounds content and antioxidant activity in skin, pulp, seed, cane and leaf of five native grape cultivars in West Azerbaijan province, Iran. Food Chem 199, 847\u2013855 (2016). https:\/\/doi.org\/10.1016\/j.foodchem.2015.12.083","journal-title":"Food Chem"},{"key":"3479_CR10","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s43032-021-00653-9","volume":"29","author":"S Shojaei-Zarghani","year":"2022","unstructured":"S. Shojaei-Zarghani, M. Rafraf, Resveratrol and markers of polycystic ovary syndrome: a systematic review of animal and clinical studies. Reprod Sci 29, 2477\u20132487 (2022). https:\/\/doi.org\/10.1007\/s43032-021-00653-9","journal-title":"Reprod Sci"},{"key":"3479_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0427-7","volume":"11","author":"S Furat Rencber","year":"2018","unstructured":"S. Furat Rencber, S. Kurnaz Ozbek, C. Eraldem\u0131r et al. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res 11, 55 (2018). https:\/\/doi.org\/10.1186\/s13048-018-0427-7","journal-title":"J Ovarian Res"},{"key":"3479_CR12","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1016\/j.clnu.2021.02.004","volume":"40","author":"A Mansour","year":"2021","unstructured":"A. Mansour, M. Samadi, M. Sanginabadi et al. Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clin Nutr 40, 4106\u20134112 (2021). https:\/\/doi.org\/10.1016\/j.clnu.2021.02.004","journal-title":"Clin Nutr"},{"key":"3479_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10863-022-09942-7","volume":"54","author":"B Yuan","year":"2022","unstructured":"B. Yuan, S. Luo, L. Feng, J. Wang, J. Mao, B. Luo, Resveratrol regulates the inflammation and oxidative stress of granulosa cells in PCOS via targeting TLR2. J Bioenerg Biomembr 54, 191\u2013201 (2022). https:\/\/doi.org\/10.1007\/s10863-022-09942-7","journal-title":"J Bioenerg Biomembr"},{"key":"3479_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021). https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3479_CR15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"J.P. Higgins, D.G. Altman, P.C. G\u00f8tzsche et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 343, d5928 (2011). https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ."},{"key":"3479_CR16","doi-asserted-by":"publisher","unstructured":"J.P. Higgins, S.G. Thompson, J. J. Deeks et al. Measuring inconsistency in meta-analyses. BMJ. 327, 557\u2013560 (2003). https:\/\/doi.org\/10.1136\/bmj.327.7414.557","DOI":"10.1136\/bmj.327.7414.557"},{"key":"3479_CR17","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s10815-019-01461-6","volume":"36","author":"M Bahramrezaie","year":"2019","unstructured":"M. Bahramrezaie, F. Amidi, A. Aleyasin et al. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. J Assist Reprod Genet. 36, 1701\u20131712 (2019). https:\/\/doi.org\/10.1007\/s10815-019-01461-6","journal-title":"J Assist Reprod Genet."},{"key":"3479_CR18","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1210\/jc.2016-1858","volume":"101","author":"B Banaszewska","year":"2016","unstructured":"B. Banaszewska, J. Wroty\u0144ska-Barczy\u0144ska, R.Z. Spaczynski, L. Pawelczyk, A.J. Duleba, Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 101, 4322\u20134328 (2016). https:\/\/doi.org\/10.1210\/jc.2016-1858","journal-title":"J Clin Endocrinol Metab."},{"key":"3479_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","volume":"77","author":"CM Burt Solorzano","year":"2012","unstructured":"C.M. Burt Solorzano, J.P. Beller, M.Y. Abshire, J.S. Collins, C.R. McCartney, J.C. Marshall, Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids. 77, 332\u2013337 (2012). https:\/\/doi.org\/10.1016\/j.steroids.2011.12.007","journal-title":"Steroids."},{"key":"3479_CR20","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1210\/jc.2008-2606","volume":"94","author":"SK Blank","year":"2009","unstructured":"S.K. Blank, C.R. McCartney, S. Chhabra, K.D. Helm, C.A. Eagleson, R.J. Chang, J.C. Marshall, Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls-implications for regulation of pubertal maturation. J Clin Endocrinol Metab. 94, 2360\u20132366 (2009). https:\/\/doi.org\/10.1210\/jc.2008-2606","journal-title":"J Clin Endocrinol Metab."},{"key":"3479_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-016-0173-x","volume":"14","author":"V De Leo","year":"2016","unstructured":"V. De Leo, M.C. Musacchio, V. Cappelli, M.G. Massaro, G. Morgante, F. Petraglia, Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 14, 38 (2016). https:\/\/doi.org\/10.1186\/s12958-016-0173-x","journal-title":"Reprod Biol Endocrinol."},{"key":"3479_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"D. Dewailly, G. Robin, M. Peigne, C. Decanter, P. Pigny, S. Catteau-Jonard, Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 22, 709\u2013724 (2016). https:\/\/doi.org\/10.1093\/humupd\/dmw027","journal-title":"Hum Reprod Update."},{"key":"3479_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00003081-197803000-00003","volume":"21","author":"F Naftolin","year":"1978","unstructured":"F. Naftolin, G. Tolis, Neuroendocrine regulation of the menstrual cycle. Clin Obstet Gynecol 21, 17\u201329 (1978). https:\/\/doi.org\/10.1097\/00003081-197803000-00003","journal-title":"Clin Obstet Gynecol"},{"key":"3479_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3892\/etm.2014.1544","volume":"7","author":"W Chao","year":"2014","unstructured":"W. Chao, Z. Xuexin, S. Jun, C. Ming, J. Hua, G. Li, C. Tan, W. Xu, Effects of resveratrol on cell growth and prolactin synthesis in GH3 cells. Exp Ther Med. 7, 923\u2013928 (2014). https:\/\/doi.org\/10.3892\/etm.2014.1544","journal-title":"Exp Ther Med."},{"key":"3479_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.clineuro.2011.10.035","volume":"114","author":"C Wang","year":"2012","unstructured":"C. Wang, Z.Q. Hu, M. Chu, Z. Wang, W.G. Zhang, L.Z. Wang, C.G. Li, J.S. Wang, Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors. Clin Neurol Neurosurg. 114, 241\u2013248 (2012). https:\/\/doi.org\/10.1016\/j.clineuro.2011.10.035","journal-title":"Clin Neurol Neurosurg."},{"key":"3479_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","volume":"58","author":"Q Liu","year":"2019","unstructured":"Q. Liu, Y.J. Xie, L.H. Qu, M.X. Zhang, Z.C. Mo, Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol 58, 447\u2013453 (2019). https:\/\/doi.org\/10.1016\/j.tjog.2019.05.003","journal-title":"Taiwan J Obstet Gynecol"},{"key":"3479_CR27","doi-asserted-by":"publisher","first-page":"e2100457","DOI":"10.1002\/mnfr.202100457","volume":"65","author":"A Liang","year":"2021","unstructured":"A. Liang, L. Huang, H. Liu et al. Resveratrol improves follicular development of pcos rats by regulating the glycolytic pathway. Mol Nutr Food Res. 65, e2100457 (2021). https:\/\/doi.org\/10.1002\/mnfr.202100457","journal-title":"Mol Nutr Food Res."},{"key":"3479_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"E. Diamanti-Kandarakis, A.G. Papavassiliou, S.A. Kandarakis, G.P. Chrousos, Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 18, 280\u2013285 (2007). https:\/\/doi.org\/10.1016\/j.tem.2007.07.004","journal-title":"Trends Endocrinol Metab."},{"key":"3479_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000341683","volume":"40","author":"D Macut","year":"2013","unstructured":"D. Macut, J. Bjeki\u0107-Macut, A. Savi\u0107-Radojevi\u0107, Dyslipidemia and oxidative stress in PCOS. Front Horm Res. 40, 51\u201363 (2013). https:\/\/doi.org\/10.1159\/000341683","journal-title":"Front Horm Res."},{"key":"3479_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.steroids.2011.12.002","volume":"77","author":"RA Wild","year":"2012","unstructured":"R.A. Wild, Dyslipidemia in PCOS. Steroids. 77, 295\u2013299 (2012). https:\/\/doi.org\/10.1016\/j.steroids.2011.12.002","journal-title":"Steroids."},{"key":"3479_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1001\/archderm.135.9.1041","volume":"135","author":"D Thiboutot","year":"1999","unstructured":"D. Thiboutot, K. Gilliland, J. Light, D. Lookingbill, Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 135, 1041\u20131045 (1999). https:\/\/doi.org\/10.1001\/archderm.135.9.1041","journal-title":"Arch Dermatol"},{"key":"3479_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archderm.1987.01660260079018","volume":"123","author":"SB Reingold","year":"1987","unstructured":"S.B. Reingold, R.L. Rosenfield, The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol 123, 209\u2013212 (1987)","journal-title":"Arch Dermatol"},{"key":"3479_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/09513590.2020.1859474","volume":"37","author":"F Ramezani Tehrani","year":"2021","unstructured":"F. Ramezani Tehrani, S. Behboudi-Gandevani, R. Bidhendi Yarandi, M. Saei Ghare Naz, E. Carmina, Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecol Endocrinol. 37, 392\u2013405 (2021). https:\/\/doi.org\/10.1080\/09513590.2020.1859474","journal-title":"Gynecol Endocrinol."},{"key":"3479_CR34","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/molehr\/gat065","volume":"19","author":"M Lebbe","year":"2013","unstructured":"M. Lebbe, T.K. Woodruff, Involvement of androgens in ovarian health and disease. Mol Hum Reprod. 19, 828\u2013837 (2013). https:\/\/doi.org\/10.1093\/molehr\/gat065","journal-title":"Mol Hum Reprod."},{"key":"3479_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1511-7","volume":"10","author":"A Ochiai","year":"2019","unstructured":"A. Ochiai, K. Kuroda, R. Ozaki et al. Resveratrol inhibits decidualization by accelerating downregulation of the CRABP2-RAR pathway in differentiating human endometrial stromal cells. Cell Death Dis. 10, 276 (2019). https:\/\/doi.org\/10.1038\/s41419-019-1511-7","journal-title":"Cell Death Dis."},{"key":"3479_CR36","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.4049\/jimmunol.164.12.6509","volume":"164","author":"SK Manna","year":"2000","unstructured":"S.K. Manna, A. Mukhopadhyay, B.B. Aggarwal, Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164, 6509\u20136519 (2000). https:\/\/doi.org\/10.4049\/jimmunol.164.12.6509","journal-title":"J Immunol"},{"key":"3479_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1196\/annals.1329.054","volume":"1030","author":"BB Aggarwal","year":"2004","unstructured":"B.B. Aggarwal, S. Shishodia, Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030, 434\u2013441 (2004). https:\/\/doi.org\/10.1196\/annals.1329.054","journal-title":"Ann N Y Acad Sci"},{"key":"3479_CR38","doi-asserted-by":"publisher","first-page":"e13186","DOI":"10.1111\/aji.13186","volume":"83","author":"S Brenjian","year":"2020","unstructured":"S. Brenjian, A. Moini, N. Yamini, L. Kashani, M. Faridmojtahedi, M. Bahramrezaie, M. Khodarahmian, F. Amidi, Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. Am J Reprod Immunol 83, e13186 (2020). https:\/\/doi.org\/10.1111\/aji.13186","journal-title":"Am J Reprod Immunol"},{"key":"3479_CR39","doi-asserted-by":"publisher","first-page":"e02057","DOI":"10.7554\/eLife.02057","volume":"3","author":"JC Nwachukwu","year":"2014","unstructured":"J.C. Nwachukwu, S. Srinivasan, N.E. Bruno et al. Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network. Elife. 3, e02057 (2014). https:\/\/doi.org\/10.7554\/eLife.02057","journal-title":"Elife."},{"key":"3479_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12020-022-03198-2","volume":"79","author":"S Hassan","year":"2023","unstructured":"S. Hassan, M. Shah, M.O. Malik, E. Ehtesham, S.H. Habib, B. Rauf, Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial. Endocrine. 79, 208\u2013220 (2023). https:\/\/doi.org\/10.1007\/s12020-022-03198-2","journal-title":"Endocrine."},{"key":"3479_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0427-7","volume":"11","author":"S Furat Rencber","year":"2018","unstructured":"S. Furat Rencber, S. Kurnaz Ozbek, C. Eraldem\u0131r, Z. Sezer, T. Kum, S. Ceylan, E. Guzel, Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res. 11, 55 (2018). https:\/\/doi.org\/10.1186\/s13048-018-0427-7","journal-title":"J Ovarian Res."},{"key":"3479_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1210\/jc.2013-2692","volume":"99","author":"U Schube","year":"2014","unstructured":"U. Schube, M. Nowicki, P. Jogschies, V. Blumenauer, I. Bechmann, H. Serke, Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration. J Clin Endocrinol Metab. 99, 229\u2013239 (2014). https:\/\/doi.org\/10.1210\/jc.2013-2692","journal-title":"J Clin Endocrinol Metab."},{"key":"3479_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"B. Salehi, A.P. Mishra, M. Nigam et al. Resveratrol: a double-edged sword in health benefits. Biomedicines. 6, 91 (2018). https:\/\/doi.org\/10.3390\/biomedicines6030091","journal-title":"Biomedicines."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03479-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03479-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03479-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:31:47Z","timestamp":1705998707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03479-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["3479"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03479-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}